Market Research Future published a half-cooked research report on Global Hospital Acquired Infections Market. The global hospital acquired infections market is expected to grow at a CAGR of ~7.3% during the period 2016 to 2022.
A hospital acquired infection (HAI) also termed as nosocomial infection or health care associated infection is acquired in a health care facility other than the one for which the patient was admitted. HAI also includes occupational infection among hospital staff. The global hospital acquired infections market generated USD 23.7 billion in 2016 which is anticipated to deliver USD 36.16 billion at a 7.3% CAGR growth.
The growing menace of antibiotic resistant microbes coupled with growing healthcare facilities and admissions is the critical driver of the market. WHO estimates that 8.7% of hospital patients had nosocomial infections affecting over 1.4 million people worldwide. Thus a large market is easily comprehendible.
Get a sample report at https://www.marketresearchfuture.com/sample_request/2576 .
The other drivers are growing number of immune compromised patients, growing geriatric population, environmental drivers such as growing bacterial load in hospitals, crowding, poor hospital infrastructure, poor infection control practices, growing incidence of chronic diseases requiring prolonged stay in hospitals etc. Technology advancement such as gas plasma sterilization technology is expected to drive the future global HAI market.
The US government will start penalizing hospitals in 2017 under the Readmissions Reduction Program (HRRP) of the Affordable Care Act, for hospital acquired infection. This development is expected to be the strongest driver for the U.S. hospital acquired infection market.
Low awareness, poor regulations in underdeveloped regions, increasing use of bacterial resistant construction material such as ceramics and glass in hospital infrastructure, growing use of disposables, and others. The loss of patents on blockbuster antibiotics, huge market fragmentation adding pressure on prices, spurious and counterfeit products, and others are also hampering the market.
Some of the key players in this market are Becton Dickinson and company, Advanced Sterilization Products, Cantel Medical Corp., STERIS Corporation, Getinge AB, 3M Company, Belimed AG, and others.
Industry Mergers and Acquisitions:
Jan 2016 – Pfizer acquired Vicuron Pharmaceuticals a novel second-generation glycopeptide indicated for serious gram-positive bacterial infections.
September, 2016 – Pfizer acquired Medivation, Inc.
June, 2016 – Pfizer acquired Anacor Pharmaceuticals, Inc.
September, 2015 – Pfizer acquired Hospira, Inc.
Thus a host of acquisitions by Pfizer is the hot topic in the hospital-acquired infections market. Thus inorganic growth is been seen as an attractive strategy.
Browse Complete Report at https://www.marketresearchfuture.com/reports/hospital-acquired-infections-market-2576 .
Vancomycin resistant bacteria has reduced its effectiveness and has resulted in clinical failures. Greater generic penetration has resulted in pressure on the profit margin on vancomycin market.
Tigecycline expected to generate the fastest CAGR growth for the forecast period.
The market has been segmented by pathogen types, method of treatment, infection type and regions to generate a better understanding of the differential potential along these segments.
Pathogen types – viral, bacterial and fungal. Methicillin-resistant Staphylococcus aureus (MRSA) is the fastest growing nosocomial infection and has been the cause of a growing market.
Method of treatment – sterilization, chemical, radiation
Infection type – urinary tract infections, blood stream infections, surgical site infections, gastrointestinal infections, and respiratory infections.
Regions – Americas, Europe, Asia Pacific, Middle East and Africa.
Regional Analysis: North America led by the U.S. is the largest market for hospital-acquired infections. The enactment of the Hospital Readmissions Reduction Program (HRRP) under the Affordable Care Act will drive a strong CAGR growth in this market.
Europe follows in the second position with Italy, Spain, and Portugal having the highest rates of prevalence of HAI. The Asia Pacific market follows with China and India making a bulk of it. The Middle East and Africa are expected to generate a moderate growth. The poor economic conditions of the underdeveloped regions of Asia Pacific and Africa are constraints of the market growth in these regions.
More Inquire at https://www.marketresearchfuture.com/enquiry/2576 .
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
P: +1 646 845 9312